iSAP-1017

N/A

Report date: 2025/07/25 16:10:56
NME

Base Information

Drug NameiSAP-1017
Drug Alias NameiSAP-1017
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAisaipu (Beijing) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAisaipu (Beijing) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A